Disorders of the urea cycle and related enzymes

Inborn Metabolic Diseases: Diagnosis and Treatment

Volumn , Issue , 2012, Pages 297-310

  Wijburg, Frits A ^a   Nassogne, Marie Cecile ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881232876     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-15720-2_20     Document Type: Chapter

References (46)

1. Spronsen FJ, Reijngoud DJ, Verhoeven NM et al. (2006) High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthase and lyase deficiency: implications for treatment? Mol Genet Metab 89:274-276
2. Nagasaka H, Tsukahara H, Yorifuji T et al. (2009) Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects. Metbolism 58:278-282
3. Saheki T, Inoue K, Tushima A, Mutoh K, Kobayashi K (2010) Citrin deficiency and current treatment concepts. Mol Genet Metab 100:S59-S64
4. Mercimek-Mahmutoglu S, Moeslinger D, Haberle J et al. (2010) Long-term outcome of patients with argininosuccinatelyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab 100:24-28
5. Nakagawa T, Lomb DJ, Haigis MC, Guarente L (2009) SIRT5 Deacetylatescarbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137:560-570
6. Hallows WC, Smith BC, Lee S, Denu JM (2009) Ure(k)a! Sirtuins regulate mitochondria. Cell 137:404-406
7. Pappas PA, Saudubray JM, Tzakis AG et al. (2002) Serum citrulline as a marker of acute cellular rejection for intestinal transplantation Transplant Proc 34:915-917
8. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B (2000) Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 119:1496-1505
9. Ceballos I, Chauveau P, Guerin V et al. (1990) Early alteration of plasma amino acids in chronic renal failure. Clin Chim Acta 188:101-108
10. Rabier D, Narcy C, Bardet J et al. (1991) Arginine remains an essential amino acid after liver transplantation in urea cycle enzyme deficiencies. J Inherit Metab Dis 327:24-27
11. Braissant O (2010) Current concepts in the pathogenesis of urea cycle disorders. Mol Genet Metab 100:S3-S12
12. Gropman A (2010) Brain imaging in urea cycle disorders. Mol Genet Metab 100:S20-S30
13. Luksan O, Jirsa M, Eberova J et al. (2010) Disruption of OTC promoter- enhancer interaction in a patient with symptoms of ornithine carbamoyltransferase deficiency. Hum Mutat 4:E1294-E1303
14. Grunewald S, Fairbanks L, Genet S et al. (2004) How reliable is the allopurinol load in detecting carriers for ornithine transcarbamoylase deficiency? J Inherit Metab Dis 27:179-186
15. Rowe PC, Newman SL, Brusilow SW (1986) Natural history of symptomatic partial ornithine transcarbamoylase deficiency. N Engl J Med 314:541-547
16. Ray PF, Gigarel N, Bonnefont JP et al. (2000) First specific preimplantation genetic diagnosis for ornithine transcarbamoylase deficiency. Prenat Diagn 20:1048-1054
17. Arbeiter AK, Kranz B, Wingen AM et al. (2010) Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 25:1257-1265
18. McBryde KD, Kudelka TL, Kershaw DB et al. (2004) Clearance of amino acids by hemodialysis in argininosuccinatesynthetase deficiency. J Pediatr 144:536-540
19. Bunchman TE, Barletta GM, Winters JW et al. (2007) Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration. Pediatr Nephrol 22:1062-1065
20. Lai YC, Huang HP, Tsai IJ, Tsau YK (2007) High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children. Blood Purif 25:303-308
21. Westrope C, Morris K, Burford D, Morrison G (2010) Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience. Pediatr Nephrol 25:1725-30
22. Brusilow SW, Danney M, Waber LJ et al. (1984) Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 310:1630-1634
23. Enns GM (2010) Nitrogen sparing therapy revisited. Mol Genet Metab 100:S65-S71
24. Scaglia F (2010) New insights in nutritional management and amino acid supplementation in urea cycle disorders. Mol Genet Metab 100:S72-S76
25. Morris AAM, Richmond SWJ, Oddie SJ et al. (1998) N-Acetylglutamatesynthetase deficiency: favourable experience with carbamoylglutamate. J Inherit Metab Dis 21:867-868
26. Gessler P, Buchal P, Schwenk HU, Wermuth B (2010) Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency. Eur J Pediatr 169:197-199
27. Lee B, Singh RH, Rhead WJ et al. (2005) Considerations in the difficult-to-manage urea cycle disorder patient. Crit Care Clin 21:S19-S25
28. Leonard JV (2001) The nutritional management of urea cycle disorders. J Pediatr 138:S40-S45
29. Singh RH, Rhead WJ, Smith W et al. (2005) Nutritional management of urea cycle disorders. Crit Care Clin 21:S27-S35
30. Avitsland TL, Kristensen C, Emblem R et al. (2006) Percutaneous endoscopic gastrostomy in children: a safe technique with major symptom relief and high parental satisfaction. J Pediatr Gastroenterol Nutr 43:624-628
31. Kuchler G, Rabier D, Poggi-Travert F et al. (1996) Therapeutic use of carbamoylglutamate in the case of carbamoyl-phosphate synthetase deficiency 19:220-222
32. Maestri NE, McGowan KD, Brusilow SW (1992) Plasma glutamine concentration: a guide to the management of urea cycle disorders. J Pediatr 121:259-261
33. Schmidt J, Kroeber S, Irouschek A et al. (2006) Anesthetic management of patients with ornithine transcarbamoylase deficiency. Paediatr Anaesth 16:333-337
34. Oechsner M, Steen C, Sturenburg HJ et al. (1998) Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamoylase deficiency. J Neurol Neurosurg Psychiatry 64:680-682
35. Cederbaum JA, LeMons C, Rosen M et al. (2001) Psychosocial issues and coping strategies in families affected by urea cycle disorders. J Pediatr 138 [Suppl 1]:S72-S80
36. Arnon R, Kerkar N, Davis MK et al. (2010) Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr Transplant 14:796-805
37. Chang IF, Barshes NR, Bristow LJ et al. (2005) Orthotopic liver transplantation (OLT) for urea cycle disorders (UCDs): the US experience. Am J Transplant 5:337
38. Leonard JV, McKiernan PJ (2004) The role of liver transplantation in urea cycle disorders. Mol Genet Metab 81 [Suppl 1]:S74-S78
39. Meyburg J, Hoffman GF (2010) Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab 100:S77-S83
40. Bachmann (2003) Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur J Pediatr 162:S29-S33
41. Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28:407-414
42. Summar ML, Dobbelaere D, Brusilow S, Lee B (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 97: 1420-1425
43. Enns GM, Berry GT, Rhead WJ, Brusilow SW, Hamosh A (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356:2282-2292
44. Mendez-Figueroa HM, Lamance K, Sutton R, Aagaard-Tillery K, Veyver v d I (2010) Management of ornithine transcarbamoylase deficiency in pregnancy. Am J Perinatol 27:775-784
45. Kotani Y, Shiota M, Umemoto M, Tsuritani M, Hoshiai H (2010) Carbamoyl phosphate synthetase deficiency and postpartum hyperammonemia. Am J Obstet Gynecol 203:e10-e11
46. Tihtonen, Uotila J, Lahde J, Salo M, Keskinen P (2010) Risk of hyperammonemic coma in the puerperium: two cases of women with diagnosed and undiagnosed deficiency of urea cycle enzymes. Acta Obstet Gynecol Scand 89:404-406